Position in JAZZ
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$95,094,607
-$14,909,673 QoQ
Shares Held
503,013
-22.3% QoQ
Ownership
0.802%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pacer Advisors, Inc. holds $745,075,920 across 25 Biotechnology names. JAZZ ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
358,633 | $277,094,201 | |
| 2 | INCY |
Incyte Corp
|
1,741,061 | $163,868,661 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
503,013 | $95,094,607 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,549,611 | $66,462,815 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
88,863 | $39,680,884 | |
| 6 | RPRX |
Royalty Pharma plc
|
689,194 | $33,060,636 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
295,524 | $19,099,716 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
361,794 | $8,958,019 |
All Filings in JAZZ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,094,607 | 503,013 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $110,004,280 | 647,084 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $71,164,092 | 539,940 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $77,953,523 | 734,579 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $104,870,125 | 844,705 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $272,713,212 | 2,214,480 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $233,891,702 | 2,099,378 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $194,346,044 | 1,820,913 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $155,790,484 | 1,293,726 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $125,915,838 | 1,023,706 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $103,401,979 | 798,841 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $84,831,307 | 684,289 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $69,952,471 | 478,046 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $54,238,682 | 340,460 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $369,879 | 2,775 | Shares | Sole | 2022-10-18 | |
| 2021-12-31 | $797,524 | 6,260 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $875,401 | 6,723 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,062,982 | 22,872 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,036,352 | 6,305 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $1,001,193 | 6,066 | Shares | Sole | 2021-01-20 | |
| No filing history on record for this holder in this stock. | ||||||